Abstract
Purpose: The purpose of this integrative review was to examine the science regarding symptoms and quality of life (QoL) in individuals with pancreatic cancer (PC) undergoing surgery with or without adjuvant therapy.
Methods: The integrative review method was used to conduct this review of the literature. Whittemore and Knafl's (2005) updated integrative review guidelines were followed. Fourteen studies were included for review as a result of a search in Medline, PubMED, and CINAHL databases from 1995 to 2012.
Results: Several studies had methodological issues including poor response rates, small sample sizes, and heterogeneous samples that limited the generalizability of results and failed to provide a full picture of symptoms and QoL in individuals with PC after surgery with or without adjuvant therapy. Nonetheless, studies revealed the occurrence of foul stools, flatus, thirst, frequent urination, diabetes mellitus, heartburn, nausea, vomiting, weight loss, abdominal pain, fatigue, and muscle weakness were major symptom concerns in this population. In several studies, individuals with PC were found to experience significantly higher symptom severity when compared to individuals with benign pancreas conditions. More than 70% of studies that concurrently examined symptoms revealed that overall QoL or one or more domains of QoL were significantly impaired. Thus, suggesting that multiple symptoms may have a negative impact on QoL in this population.
Conclusions: Individuals with PC undergoing surgery with or without adjuvant therapy experience multiple symptoms that may have a negative impact on QoL. Methodological concerns were apparent in the previous research; thus, future research should include homogenous samples to improve the generalizability of findings and be conducted longitudinally to capture changes in symptoms and QoL over time. It is clear that additional research is needed to fully understand symptoms, the factors that influence symptoms, and the direct impact that symptoms have on QoL in this population.
Sigma Membership
Unknown
Lead Author Affiliation
Rutgers University-Camden, Camden, New Jersey, USA
Type
Presentation
Format Type
Text-based Document
Study Design/Type
Literature Review
Research Approach
N/A
Keywords:
Pancreatic Cancer, Symptoms and Quality of Life, Integrative Review of the Literature
Recommended Citation
Burrell, Sherry A.; Yeo, Theresa Pluth; and Smeltzer, Suzanne C., "State of the science: Symptoms and quality of life in individuals with pancreatic cancer undergoing surgery" (2012). INRC (Congress). 11.
https://www.sigmarepository.org/inrc/2012/presentations_2012/11
Conference Name
23rd International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Brisbane, Australia
Conference Year
2012
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
State of the science: Symptoms and quality of life in individuals with pancreatic cancer undergoing surgery
Brisbane, Australia
Purpose: The purpose of this integrative review was to examine the science regarding symptoms and quality of life (QoL) in individuals with pancreatic cancer (PC) undergoing surgery with or without adjuvant therapy.
Methods: The integrative review method was used to conduct this review of the literature. Whittemore and Knafl's (2005) updated integrative review guidelines were followed. Fourteen studies were included for review as a result of a search in Medline, PubMED, and CINAHL databases from 1995 to 2012.
Results: Several studies had methodological issues including poor response rates, small sample sizes, and heterogeneous samples that limited the generalizability of results and failed to provide a full picture of symptoms and QoL in individuals with PC after surgery with or without adjuvant therapy. Nonetheless, studies revealed the occurrence of foul stools, flatus, thirst, frequent urination, diabetes mellitus, heartburn, nausea, vomiting, weight loss, abdominal pain, fatigue, and muscle weakness were major symptom concerns in this population. In several studies, individuals with PC were found to experience significantly higher symptom severity when compared to individuals with benign pancreas conditions. More than 70% of studies that concurrently examined symptoms revealed that overall QoL or one or more domains of QoL were significantly impaired. Thus, suggesting that multiple symptoms may have a negative impact on QoL in this population.
Conclusions: Individuals with PC undergoing surgery with or without adjuvant therapy experience multiple symptoms that may have a negative impact on QoL. Methodological concerns were apparent in the previous research; thus, future research should include homogenous samples to improve the generalizability of findings and be conducted longitudinally to capture changes in symptoms and QoL over time. It is clear that additional research is needed to fully understand symptoms, the factors that influence symptoms, and the direct impact that symptoms have on QoL in this population.